Glucagon-like peptide 1 (GLP-1) is a peptide hormone that is released in response to nutrient ingestion. Postprandial GLP-1 release has been reported to be attenuated in obese subjects, but reports on the effect of weight loss on GLP-1 are conflicting. The aim of the present study was to clarify the effect of a weight-loss period and a consecutive weight-maintenance period on nutrient-stimulated GLP-1 release in obese subjects. Nutrient-stimulated (standard breakfast; 1·9 MJ) GLP-1 release was investigated in thirty-two obese subjects on three occasions: before weight loss (T1) (BMI 30·0 (SD 2·5) kg/m 2 ); after a 6-week very-low-energy diet (VLED) (T2) (BMI 27·6 (SD 2·3) kg/m 2 ); after a 3-month weight-maintenance period (T3) (BMI 27·9 (SD 2·3) kg/m 2 ). At each occasion, following a fasting blood sample the test meal was fed and blood was drawn every 30 min for 2 h relative to ingestion in order to determine plasma GLP-1, insulin, glucose and NEFA concentrations. Subjects lost 7 (SD 3·4) kg during the VLED (P, 0·0001) and regained 1 (SD 3·2) kg during the weight-maintenance period (NS). The area under the curve for nutrient-stimulated plasma GLP-1 (pmol/l £ h) was significantly decreased (P¼ 0·01) at T2 (6·8 (SD 1)) compared with T1 (12·8 (SD 2·9)) and T3 (11·1 (SD 1·5)). Since we found a rebound of concentrations after a weight-maintenance period, decrease after weight loss seems to be transient and possibly due to a negative energy balance.
Along with the attempt to find a 'cure' for the obesity epidemic, increasing attention has been given to the role of gut hormones in the development of obesity as well as in weight loss and weight maintenance. Weight loss is associated with a marked health improvement and a decreased risk of CVD and type 2 diabetes mellitus (van Gaal et al. 1997; Murphy & Bloom, 2004) . For long-term effects of weight loss, the weight-maintenance period after actual weight loss seems to be more crucial. Factors such as an increase in cognitive restraint have been shown to work beneficially for weight maintenance (Clark et al. 1994; Lejeune et al. 2003b) . Factors suggested as being related to the development of obesity are decreased physical activity and/or increased energy intake. Weight loss can thus be achieved by reducing energy intake and/ or increasing energy expenditure.
Energy intake is partly controlled by neural and humoral signals that are generated by a biological system that senses and processes food and that has impact on the satiating efficiency of food (Blundell et al. 1993) . One of the supposed mediators that is involved in the development of post-meal satiety and possibly contributes to satiation is glucagon-like peptide 1 (GLP-1) (Blundell & Näslund, 1999) .
GLP-1 is a thirty amino acid peptide hormone that is released from intestinal L cells into the circulation after a mixed meal (Holst, 1994; Näslund et al. 1999a) . Peripheral GLP-1 administration compared with saline infusions reduced food intake and suppressed appetite in normal weight-subjects (Flint et al. 1998 ) and led to lower hunger ratings and decreased energy intake during an ad libitum meal in obese subjects (Näslund et al. 1999a) . The role of GLP-1 and its possible contribution to obesity is not clear yet. One study has reported hypersecretion of GLP-1 in obese subjects (Fukase et al. 1993) . However, there also is evidence that postprandial GLP-1 release in response to carbohydrate and mixed-meal ingestion seems to be attenuated in obese subjects (Ranganath et al. 1996; Verdich et al. 2001b) . Outcomes of studies examining the effect of weight loss on GLP-1 concentrations in obese subjects are ambivalent. While increased concentrations have been found after weight loss (Näslund et al. 1999a; Verdich et al. 2001a) , others report decreased concentrations of appetite-related peptides after weight loss (Cigaina & Hirschberg, 2003) . The aim of the present study was to clarify the effect of diet-induced weight loss on GLP-1 concentrations in obese subjects and in particular the development of GLP-1 concentrations during consecutive weight maintenance following weight loss.
Methods

Subjects
Forty subjects were recruited by advertisements in local newspapers or flyers at the Maastricht University that included the inclusionary criteria for the present study. Eight subjects did not complete the study and only data for the thirty-two completers are presented.
Thirty-two overweight or obese class 1 (BMI 30·1 (SD 2·6) kg/m 2 ) subjects (average age 44 (SD 9) years; twenty-three women, mean age 43 (SD 8) years, range 20 -59 years; nine men, mean age 46 (SD 12) years, range 28 -60 years), according to the classification of the WHO (BMI $ 25 and , 34·9 kg/m 2 ) (World Health Organization, 1998), participated in the study. Selection criteria included being in good health, not taking any medications, and no history of diabetes or chronic disease.
Informed written consent was obtained and the study was approved by the medical ethics committee of the Maastricht University.
Experimental design
A repeated measurement design was applied to the thirty-two selected subjects including three visits: before weight loss (T1); after a 6-week weight-loss period (T2) with a verylow-energy diet (VLED); after a 12-week weight-maintenance period (T3). Each time, subjects came to the laboratory in the morning in a fasted state. They were instructed to fast from 22.00 hours the night before the test day. After the questionnaires were completed, urine samples were collected, resting energy expenditure (REE) was measured and an indwelling cannula (Baxter BV, Utrecht, The Netherlands) was inserted in an antecubital vein. After 20 min of rest, subjects received a standard breakfast. The breakfast (1·9 MJ) had an energy density of 3·9 kJ/g and consisted of two slices of brown bread (100 g), baked egg (85 g) and 300 ml skimmed milk. The distribution of energy was 48·8 energy percent (E %) carbohydrates, 28·5 E % protein and 22·6 E % fat.
Blood samples were taken for a total of 2 h, every 0.5 h relative to ingestion of the breakfast for determining plasma GLP-1, insulin, glucose and NEFA concentrations.
To determine the appetite profile, subjects rated their subjective feeling of hunger and satiety (how satiated do you feel) on anchored 100 mm visual analogue scales with the left anchor 'not at all' and the right anchor 'extremely' 15 min before the meal (time point 0), immediately after the meal (time point 30), and during the rest of the test day every 30 min relative to the measurement after the meal for a total of 120 min.
After the baseline measurements at the first appointment, a VLED intervention followed for 6 weeks to promote weight loss. The VLED (Optifast w ; Novartis Consumer Health, Osthofen, Germany) was supplied in three sachets per d, dissolved in water to obtain a milk shake, pudding or soup. Three sachets provided 2540 kJ/d, consisting of 52·5 g protein (35 E %), 13·5 g fat (20 E %) and 67·5 g carbohydrate (45 E %). A maximum of 200 g vegetable or fruit were allowed in addition to the VLED.
After the 6 weeks of the VLED all measurements were repeated. The last appointment followed after a 12-week weight-maintenance period. During the weight-maintenance period subjects had no specific instructions about diet or physical activity.
Anthropometry
All anthropometrical data were obtained three times, before and after weight loss and after weight maintenance (Table 1) .
For all subjects, body weight was measured on a digital balance (Seca, Hamburg, Germany), with subjects in underwear, in a fasted state, and after voiding their bladder. Height was measured using a wall-mounted stadiometer (Seca, Hamburg, Germany). The BMI was calculated as body weight/height 2 (kg/m 2 ). The distribution of fat was determined by measuring the waist and hip circumferences and calculation of the waist:hip ratio. The waist circumference was measured at the site of the smallest circumference between the rib cage and the ileac 2 H concentrations in the urine samples were measured using an isotope ratio MS (Micromass Optima, Manchester, UK). Total body water was determined by dividing the measured 2 H dilution space by 1·04 (Schoeller et al. 1980) .
Fat-free mass (FFM) was calculated by dividing the total body water by the hydration factor 0·73. By subtracting FFM from body weight, fat mass was obtained. Percentage of body fat was calculated according to the equation of Siri (1956) .
Resting energy expenditure and substrate oxidation REE was measured by means of an open-circuit ventilated hood system. Subjects came to the laboratory in the morning by car or by bus to minimise the amount of physical activity before the test. REE was measured at the beginning of each of the test days with subjects in a fasted state while lying supine for 30 min. Gas analyses were performed by a paramagnetic O 2 analyser (Servomex type 500A; Servomex Dontrols Ltd, Crowborough, Sussex, UK) and an IR CO 2 analyser (Servomex type 500A), similar to the analysis system described by Schoffelen et al. (1997) . Calculation of REE was based upon Weir's formula (Weir, 1949) . RQ was calculated as CO 2 produced/O 2 consumed.
Fat oxidation was calculated using the following equation (Peronnet & Massicotte, 1991) :
Ambient temperature
Data on 24 h average ambient temperature were supplied by the Royal Dutch Meteorological Institute and were collected at a location near the university (Maastricht, Beek; 518 North, 68 East).
Attitude towards eating
Eating behaviour was analysed at the beginning of each test day using a validated Dutch translation of the three-factor eating questionnaire (Stunkard & Messick, 1985; Westerterp-Plantenga et al. 1999) . Cognitive restrained and unrestrained eating behaviour (factor 1, twenty-one items), emotional eating and disinhibition (factor 2, sixteen items) and the subjective feeling of hunger (factor 3, fourteen items) were scored.
Blood parameters
Blood samples for GLP-1 were taken in iced syringes and mixed with EDTA and 40 ml dipeptidyl-peptidase IV inhibitor (DPP-IV inhibitor; Linco Research, St Charles, MO, USA) that prevents degradation of hormones such as GLP-1 by the DPP-IV enzyme. Blood samples for other blood parameters were mixed with EDTA to prevent clotting. Plasma was obtained by centrifugation for 10 min at 2800 g at 48C. Plasma was collected, frozen in liquid N 2 and stored at 2 208C for analysis.
GLP-1 concentrations were measured using an ELISA (EGLP-35K; Linco Research Inc.) for non-radioactive quantification of biologically active forms of glucagon-like peptide. The assay has an intra-assay CV of 8 % or less and an interassay CV of 12 % or less. Sensitivity of the analysis is 2 pmol/l (Nathan et al. 1992) .
Plasma glucose concentrations were determined using the hexokinase method (Glucose HK 125 kit; ABX diagnostics, Montpellier, France). The WAKO NEFA C-kit (Wako Chemicals, Neuss, Germany) was used to determine NEFA concentrations.
Insulin concentrations were measured using a RIA kit (Insulin RIA-100; Pharmacia, Uppsala, Sweden).
Statistical procedures
Data are presented as means with their standard errors or as means and standard deviations. Sex differences were assessed using factorial ANOVA and corrected for baseline differences. All figures show changes from fasting plasma concentrations at each time of blood sampling (D) at the three testing occasions T1, T2 and T3 or area under the curve. Differences for blood parameters, appetite profile and anthropometrical data between T1, T2 and T3 were determined by ANOVA for repeated measures and Sheffé F post hoc test (Statview SE Graphicse, Abacus Concepts Inc, Berkeley, CA, USA). Area under the curve was calculated as incremental area under the curve over time (2 h), using the trapezoidal method. Pearson correlation coefficients, r, were calculated to determine the relationship between REE and FFM.
A possible relationship between changes in the different appetite ratings and in GLP-1 concentrations after a meal were assessed by regression analysis. Whether the decrease in GLP-1 release after weight loss compared with before weight loss was related to D body fat, D body weight and age was tested with the same method. All analyses were performed with Statview SE Graphicse. The level of significance was set at P, 0·05.
Results
Anthropometrical results
Anthropometrical data are shown in Table 1 .
All anthropometrical results were compared between men and women using factorial ANOVA. There was no sex effect, except for weight loss. Women lost 5·8 (SD 2·7) kg, while men lost 9·8 (SD 2·8) kg (P, 0·001). Thus, all further data have been taken together for men and women.
During the 6-week VLED, subjects had lost 8 (range 1-14·8) % of their weight. This was followed by a non-statistically significant 1·2 % regain during the 12-week weight-maintenance period. With regard to body composition, reduction of percentage fat mass was significant after weight loss (F 1,31 61·8; P, 0·0001; compared with baseline) as well as after weight maintenance (F 1,31 60·7; P, 0·0001). FFM decreased slightly, but not statistically significant over time. At T2 as well as at T3 factor 1 of the three-factor eating questionnaire (restraint scores) was significantly increased (F 1,31 56·4; P, 0·0001; and F 1,31 52·3; P, 0·0001, respectively) compared with T1. In addition, factor two (disinhibition) and three (hunger) were significantly reduced (F 1,31 8·3; P, 0·05 and F 1,31 7·7; P, 0·05 respectively) compared with baseline.
RQ was significantly reduced at T2 compared with T1 (F 1,31 52·9; P, 0·0001), indicating increased fat oxidation, and significantly increased at T3 compared with T2 (F 1,31 54·8; P,0·0001), indicating normal substrate oxidation again. At all time points REE was significantly related to FFM before weight loss (T1, r 0·81; P, 0·0001), after weight loss (T2, r 0·43; P, 0·05) and after weight maintenance (T3, r 0·65; P,0·05) (Fig. 1 ).
Blood parameters
After weight loss, mean plasma GLP-1 (pmol/l) concentration in the fasting blood sample tended to be lower compared with before weight loss (2·6 (SEM 0·61) v. 4·7 (SEM 1·3)), (F 1,31 60·7; P¼0·06). Decrease in baseline GLP-1 concentrations after weight loss were unrelated to decreases in body weight or body fat. Fasting GLP-1 concentrations at T3 (4·1 (SEM 0·9)) were comparable with fasting concentrations at T1 (4·7 (SEM 1·3)).
Plasma GLP-1 concentrations expressed as change from the fasting blood sample (D) were significantly increased after ingestion of the breakfast before weight loss (T1) and after weight maintenance (T3). Post hoc testing revealed a significant increase at 30, 60, 90 and 120 min at both occasions (T1, F 1,31 8·2; P, 0·05, F 1,31 8·0; P,0·05, F 1,31 7·8; P, 0·05, F 1,31 7·9; P, 0·05 and T2, F 1,31 8·3; P,0·05, F 1,31 7·7; P, 0·05, F 1,31 7·8; P, 0·05, F 1,31 7·9; P, 0·05). After weight loss (T2), plasma GLP-1 concentrations after breakfast were not significantly different from fasting plasma concentrations.
The changes in plasma GLP-1 concentrations were significantly lower after weight loss compared with before weight loss at 60 min after breakfast (0·83 (SEM 0·48) v. 2·5 (SEM 0·52)) (F 1,31 24·9; P, 0·001).
The area under the curve for plasma GLP-1 concentrations before weight loss (12·8 (SEM 2·9)) and after weight maintenance (11·1 (SEM 1·5)) were significantly higher compared with after weight loss (6·8 (SEM 1·0)) (F 2,30 15·7; P, 0·01 compared with T1 and F 2,30 14·2; P, 0·01 compared with T3) (Fig. 2) .
Fasting insulin concentrations at T1 (11·5 (SEM 1·08)), T2 (11·5 (SEM 0·8)) and T3 (11·6 (SEM 1·2)) were not different. Plasma insulin concentrations were significantly increased compared with fasting concentrations after breakfast at 30, 60, 90 and 120 min at T1 (F 1,31 8·2; P, 0·05, F 1,31 11·5; P, 0·05, F 1,31 10·1; P, 0·05, F 1,31 8·3; P, 0·05), T2 (F 1,31 8·0; P, 0·05, F 1,31 11·1; P, 0·05, F 1,31 9·4; P,0·05, F 1,31 8·8; P, 0·05) and T3 (F 1,31 8·2; P, 0·05, F 1,31 11·5; P, 0·05, F 1,31 10·1; P, 0·05, F 1,31 8·3; P, 0·05). No differences were observed between T1, T2 and T3 in insulin concentrations (Fig. 3) . Insulin resistance calculated using homeostasis model assessment (Kanauchi et al. 2003) showed no differences in insulin resistance after weight loss (2·53 (SEM 0·26)) compared with before weight loss (2·54 (SEM 0·25)).
Plasma glucose concentrations were significantly increased at 60 min after breakfast compared with fasting concentrations at T1 (5·52 (SEM 0·12) v. 6·44 (SEM 0·26)) (F 1,31 9·3; P, 0·05), T2 (5·07 (SEM 0·10) v. 6·08 (SEM 0·23)) (F 1,31 9·9; P,0·05) and T3 (5·36 (SEM 0·12) v. 6·61 (SEM 0·32)) (F 1,31 10·7; P, 0·05). No differences were observed between T1, T2 and T3 (Fig. 4) .
Fasting plasma NEFA concentrations were 417·4 (SEM 27·5), 505·7 (SEM 38·7) and 416·8 (SEM 26·9) mmol/l at T1, T2 and T3 respectively.
These concentrations decreased over time at T1, T2 and T3. The decreases compared with fasting concentrations (D) were significant at 60, 90 and 120 min before weight loss (F 1,31 9·3; P, 0·05, F 1,31 9·9; P, 0·05, F 1,31 11·8; P,0·05), after weight loss (F 1,31 9·1; P, 0·05, F 1,31 10·0; P, 0·05, F 1,31 12·0; P, 0·05) and after weight maintenance (F 1,31 9·1; P, 0·05, F 1,31 9·5; P, 0·05, F 1,31 10·7; P, 0·05). The area under the curve for NEFA concentrations (mmol/l £ 2 h) was significantly higher at T2 (598·2 (SEM 47·9)) compared with T1 (435·7 (SEM 23·2)) (F 2,30 19·4; P, 0·01) and compared with T3 (471·8 (SEM 34·1)) (F 2,30 22·6; P,0·01) (Fig. 5) .
Appetite ratings
Hunger ratings (Fig. 6 ) did not differ significantly between T1, T2 and T3 at baseline, at 30, 60 and 90 min. Hunger scores decreased after breakfast at T1, T2 and T3. Hunger was significantly decreased at 120 min after weight loss compared with before weight loss (F 2,30 4·64; P, 0·05).
Satiety ratings increased after breakfast compared with fasted ratings at T1, T2 and T3 and stayed elevated compared with the fasted ratings throughout the 2 h of measurement. No differences between T1, T2 and T3 were observed over time (Fig. 7) .
Appetite ratings were not related to plasma GLP-1 concentrations.
Discussion
The present study shows decreased plasma GLP-1 concentrations after modest weight loss in overweight and obese subjects. After a weight-maintenance period of 3 months GLP-1 concentrations rebound to a level similar to before weight loss. After weight loss, not only fasting GLP-1 concentrations seemed to be decreased compared with before weight loss, but it appears that nutrient-stimulated GLP-1 release was disturbed after weight loss as well.
This observation might be an effect of the semi-solid VLED that the subjects followed during weight loss. A study comparing a liquid and a solid test meal in healthy, normal-weight subjects revealed a difference in gastric-emptying time, but not in small-bowel transit time for a liquid and a solid test meal (Bennink et al. 1999) . Altered gastric emptying rates, and increased proximal absorption rates of a liquid test meal in obese subjects (Wisen & Johansson, 1992) , possibly resulting in less food reaching the distal intestine, are suggested as a possible explanation for decreased GLP-1 release (Vilsboll et al. 2003) . Thus, the absorption rate of the semi-solid VLED in the presence of a negative energy balance might have led to the decrease of GLP-1 secretion after weight loss in the overweight and obese subjects. It needs to be taken into consideration that the reported results in the present study also might be due to a decreased stimulation of the Lcells. Peptide YY is a peptide co-localised with GLP-1 in the L-cells of the gut. GLP-1 infusion studies showed significantly decreased peptide YY concentrations as a response to GLP-1 infusion, giving evidence that L-cell secretion is regulated in part by GLP-1 itself through negative feedback regulation (Näslund et al. 1999b; Hansen et al. 2004) . Since in those studies GLP-1 concentrations were elevated to supraphysiological levels (Näslund et al. 1999b) , the question remains in how far the results apply to rather a low range of physiological GLP-1 concentrations in the present study (Flint et al. 2001) .
During the weight-maintenance period subjects appeared to have stable body weight. Surprisingly, after the 3 months weight-maintenance period, GLP-1 concentrations were rebounded back to a level comparable with before weight loss. The decrease of GLP-1 secretion after weight loss might be due to a negative energy balance and may suggest that GLP-1 might play a role as a neuroendocrine factor signalling energy deficiency. The overall pattern of GLP-1 release during T1, T2 and T3 is following the biphasic pattern, that has been described before (Herrmann et al. 1995) . GLP-1 release has been reported as attenuated in obese subjects compared with normal-weight subjects (Ranganath et al. 1996) . This observation has been explained by increased DPP-IV activity, for example (Lugari et al. 2004) . However, based upon the literature on DPP-IV activity in obese subjects, where abnormally increased DPP-IV activity could be observed in the obese even after substantial weight loss, it seems unlikely that altered DPP-IV activity is an explanation for different GLP-1 release at T1, T3 and T2 in the present study.
Due to the negative energy balance during weight loss, NEFA concentrations were increased after weight loss compared with before weight loss. An increase in plasma NEFA has been found to inhibit carbohydrate-mediated GLP-1 secretion (Ranganath et al. 1996 (Ranganath et al. , 1999 , so that increased plasma NEFA after weight loss in the present study, might in part contribute to decreased GLP-1 secretion after the standard breakfast.
As expected, the RQ measured after the VLED was reduced (Lejeune et al. 2003a) , indicating increased fat oxidation. RQ was increased again after 3 months of weight maintenance. REE as a function of FFM did not change over time. Since the main determinant of REE is FFM (Ravussin & Bogardus, 1989 ) and FFM did not change over time either, this result is not surprising. Subjects mainly lost fat mass, as can be seen in the significant reduction in percentage fat mass. Weight lost during the VLED was comparable with weight loss over this period of time in other studies (Lejeune et al. 2003a; Kovacs et al. 2004 ) and consisted mainly of fat mass, which seems to be favourable for the prevention of weight regain. This is in line with studies showing that weight regain was slower, when body weight regained consisted of a greater FFM (Pasman et al. 1999; Westerterp-Plantenga et al. 2004) . Weight loss was 6 kg on average. This means that subjects consumed an average energy of 4·2 MJ/d, providing evidence for a very negative energy balance, but also showing that subjects did not stick to the VLED completely. The difference of 1·6 MJ/d cannot be explained by the additional intake of 200 g fruit or vegetables.
During a weight-maintenance period subjects usually regain weight (Lejeune et al. 2003a,b) . Subjects in the present study did not regain weight significantly during weight maintenance. Part of an explanation for this might be either individual motivation or the weather (Plasqui et al. 2003) Another important factor in successful weight maintenance is the restraint status of the subjects, which was increased significantly after weight loss and stayed increased after weight maintenance. It has been shown that, on the individual level, differences in successful weight maintenance after an energy-restriction period are related to increases in cognitively restrained eating behaviour during the energy-restriction phase (Clark et al. 1994; Pekkarinen et al. 1996; Westerterp-Plantenga et al. 1998; Lejeune et al. 2003b ). This was supported by a decrease in disinhibition and hunger during weight loss and weight maintenance.
Differences in hunger and satiety ratings were observed at only one time point after weight loss compared with before weight loss, an observation that is similar to reports from other studies (Lejeune et al. 2003a) . Ratings were not different after the weight-maintenance period either. Again, this might be due to the weather or could be explained by lower energy requirements due to weight loss.
Evaluating the hunger and satiety ratings as well as the blood parameters it is important to mention that the size of the test meal was the same at every occasion, although energy requirements changed. This is a procedure similar to other dietary-induced weight-loss studies (Verdich et al. 2001b) .
Different from other studies, no relationship between satiety ratings and GLP-1 concentrations were observed in the present study. GLP-1 release in the present study was exclusively meal induced. Many studies so far have been working with GLP-1 infusions, leading to an increase in GLP-1 concentrations up to about 50 pmol/l (Flint et al. 1998) . A meta-analysis has shown that the effect of GLP-1 on the reduction of energy intake is dose dependent (Verdich et al. 2001b) . The present study only shows a meal-related increase in GLP-1 concentrations of about 2·5 pmol/l. This elevation might not be strong enough to have a significant impact on satiety sensation. Another study that investigated meal-induced GLP-1 release did not find a clear effect of GLP-1 on satiety either (Verdich et al. 2001b) , although investigating a meal of 2·5 MJ, 0·5 MJ more than what was used in the present study and a meal-related increase in GLP-1 of about 6 pmol/l. Decrease in hunger ratings was not related to the increase in GLP-1 concentrations after weight maintenance. Both rather seem to reflect a new state of energy balance achieved.
One important shortcoming of the present study that needs to be mentioned is the comparison with a control group; that and more research is needed to compare the outcome and results concerning the effect of weight loss by means of a semi-solid diet on GLP-1 release.
In conclusion, nutrient-stimulated GLP-1 release was decreased after weight loss, but rebounded to a level similar to before weight loss after a weight-maintenance period. The rebound in nutrient-stimulated GLP-1 release makes it likely that the absence of nutrient-stimulated GLP-1 release after weight loss is transient and might be due to a negative energy balance.
